The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders
Fanny Legrand(Université d'Angers), Amy D. Klion(Jiangsu Institute of Parasitic Diseases), Michelle Makiya(National Institute of Allergy and Infectious Diseases), Mark Raffeld(National Cancer Institute), Varghese Palath(Sunesis (United States)), Olga Šimáková(National Institutes of Health), Nenad Tomašević(Regenxbio (United States)), John Leung(Tufts University), Mark Baer, Irina Marić(Center for Cancer Research), Geoffrey Yarranton, Chyi‐Chia Richard Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Christopher Bebbington(Curtin University), Zengfang Wang(Cancer Institute (WIA))
Cited by 68
Related Papers
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
|Journal of Allergy and Clinical Immunology|2009|618
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546